CLASS
Recent news mentioning CLASS
- — Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
- — INVESTOR DEADLINE: Innventure, Inc. (INV) Investors with Substantial Losses Have Opportunity to Lead the INNVENTURE Class Action Lawsuit Before October 27, 2026
- — Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
- — UWMC INVESTOR ALERT: UWM Holdings Corporation Investors with $150K+ Losses Have Opportunity to Lead UWM Class Action Lawsuit
- — HDB ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages HDFC Bank Limited (NYSE: HDB) Investors to Contact its Legal Team Regarding Securities Fraud Class Action Lawsuit
- — DNOW INVESTOR DEADLINE: DNOW Inc. Investors with Substantial Losses Have Opportunity to Lead the DNOW Class Action Lawsuit Before October 2, 2026
- — Pentair plc (PNR) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 2, 2026 Lead Plaintiff Deadline
- — Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
- — Wix.com (WIX) Faces Securities Class Action Amid Scrutiny Over Vibe Coding Transition, Competitive and Financial Positioning - Hagens Berman
- — Cogent Communications Holdings Securities Fraud Class Action Result of Undisclosed Demand and Backlog Issues and approximately 29% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP
- — INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026
- — REGN 1-WEEK DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
Appears alongside
Browse the full archive →